Dambkowski Carl bought APGE
April 1, 2026 · Form 4 insider transaction
Dambkowski Carl bought 4,125 shares of Apogee Therapeutics Inc at $22.86 per share, a transaction worth $94.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,125
Price
$22.86
Total value
$94.3K
InsiderDambkowski Carl
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after213,898
OwnershipDirect
10b5-1 planNo
AmendedNo